Researchers in the United States are looking for adults who experience motion sickness for a clinical study for a new investigational medication for motion sickness. Qualified participants will be reimbursed for their time and participation.
You may qualify to join the study if you:
The study duration is generally three visits consisting of a screening visit, a travel assessment, and an end of study visit.
The travel portion of the study will include a boat trip to assess your symptoms of motion sickness in this situation.
This study is sponsored by
2200 Pennsylvania Ave
NW Suite 300E
Washington, DC 20037
© 2021 Vanda Pharmaceuticals